Navigation Links
Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
Date:3/18/2013

GENEVA, March 19, 2013 /PRNewswire/ --


  • Partnership is a novel cross-sector collaboration, responding to the United Nations call to tackle non-communicable diseases (NCDs)
  • Initiative goes beyond awareness-raising campaigns by prompting behavioral changes
  • Strategically combining expertise from pharmaceutical and humanitarian sectors, this initiative is expected to reach three million people

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced today a partnership on NCD prevention. The two-year partnership involves support from both organizations to design a behavioral change-based toolkit that promotes healthy lifestyle choices at national and community levels. Through its volunteer network and community-based expertise, the IFRC will make the toolkit available to approximately 3 million people worldwide.

The four main NCDs- cardiovascular diseases, cancer, chronic respiratory diseases and diabetes - kill three in five people worldwide, with 80 percent of NCD-related deaths occurring in low- and middle-income countries.

Because 50 percent of NCDs are avoidable, the IFPMA-IFRC partnership enhances efforts by both organizations to combat NCDs worldwide and support IFRC community interventions to reduce the impact of these diseases locally. Since releasing its Framework for Action on NCDs in 2011, IFPMA has delivered a series of research projects and health education initiatives to identify new ways to help people fight NCDs.

"By leveraging IFRC's and IFPMA's shared goal of fighting NCDs, this novel partnership brings synergy and creativity to fighting these diseases globally," says Eduardo Pisani , IFPMA Director General.

One of IFRC's core strengths lies in community volunteers' ability to tackle the underlying social, behavioral and environmental factors that determine good health through their on-the-ground work. "Changing behaviors by eliminating shared risk factors can save lives. Red Cross Red Crescent volunteers, going door-to-door in their communities play a vital role in promoting healthy lifestyles," says Bekele Geleta , IFRC Secretary General. "But no one single player from the public or private sector working in silo can tackle the NCDs challenges. Fighting NCDs requires multi-stakeholders solutions."

About the IFPMA:

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.


'/>"/>
SOURCE The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
2. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
3. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
4. Sagent Pharmaceuticals Selects ProspectoRx and Clinical Pharmacology
5. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
6. Salix Pharmaceuticals Commits $1.125M to AGA Research Foundation
7. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
8. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
9. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)...  While nearly three-quarters of Americans (71%) are aware ... health, only about half report taking any steps to ... a new survey announced today by Hologic (Nasdaq: ... Osteoporosis Month, Hologic is raising awareness of this major ... Americans. Osteoporosis is a disease that causes ...
(Date:4/29/2016)... 29, 2016 Acquisition Expands ... Product Development Capabilities in North America ... . Indegene ( http://www.indegene.com ), ... acquisition of Skura Corporation,s life science business. Skura,s ... sales enablement technology for life science organizations and ...
(Date:4/28/2016)...  While Abbott,s announced purchase of St. Jude ... and stent business, healthcare research firm Kalorama Information ... into patient monitoring.  Kalorama said that patient monitoring ... with double-digit growth expected the next 5 years, ... Patient Monitoring . Abbott Laboratories agreed to ...
Breaking Medicine Technology:
(Date:5/2/2016)... , ... May 02, 2016 , ... As directed by ... of Pennsylvania (HAP) issues its full support to allow certified nurse practitioners (CNP) to ... after they have worked under such supervision for three years and 3,600 hours. , ...
(Date:5/2/2016)... ... May 02, 2016 , ... Eating Recovery Center’s ... eating, mood and anxiety disorders, has rebranded its eating disorder program under a new ... eating disorder treatment facility on May 16. , To celebrate, ERC Chicago will ...
(Date:5/2/2016)... ... May 02, 2016 , ... The National Resident ... Main Residency Match® (“the Match”), the system through which U.S. and international medical ... record-high 30,750 positions were placed in the 2016 Match, and 29,572 were filled ...
(Date:5/2/2016)... ... May 02, 2016 , ... East Los Angeles dentist , ... can visit Dr. Assili to receive any dental extraction treatment for $40 off the ... June 30, 2016. With the lower price, patients can more easily afford extractions to ...
(Date:5/2/2016)... ... May 02, 2016 , ... Zitter Health Insights ... Patient Satisfaction Award that will recognize specialty pharmacies for their achievements in customer ... Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will be published ...
Breaking Medicine News(10 mins):